Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Fbln2 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FBLN2 mRNA | CTD | PMID:36331819 | Fbln2 | Rat | 1,1-dichloroethene | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of FBLN2 mRNA | CTD | PMID:26682919 | Fbln2 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Fbln2 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of FBLN2 mRNA | CTD | PMID:17555576 | Fbln2 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBLN2 mRNA | CTD | PMID:17942748 | Fbln2 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of FBLN2 mRNA | CTD | PMID:16467188|PMID:17942748 | Fbln2 | Rat | 17beta-estradiol | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Estradiol results in increased expression of FBLN2 mRNA | CTD | PMID:14664709|PMID:19484750 | Fbln2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBLN2 mRNA | CTD | PMID:17942748 | Fbln2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FBLN2 mRNA | CTD | PMID:15034205 | Fbln2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FBLN2 mRNA] | CTD | PMID:18200517 | Fbln2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of FBLN2 mRNA | CTD | PMID:18200517 | Fbln2 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Fbln2 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of FBLN2 mRNA | CTD | PMID:38648751 | Fbln2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of FBLN2 mRNA | CTD | PMID:30951980 | Fbln2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of FBLN2 protein | CTD | PMID:34186270 | Fbln2 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Fbln2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of FBLN2 gene | CTD | PMID:31683443 | Fbln2 | Rat | 4,4'-sulfonyldiphenol | increases methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of FBLN2 gene | CTD | PMID:31601247 | Fbln2 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of FBLN2 mRNA | CTD | PMID:28973697 | Fbln2 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Decitabine affects the expression of FBLN2 mRNA | CTD | PMID:23300844 | Fbln2 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of FBLN2 mRNA | CTD | PMID:24780913 | Fbln2 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of FBLN2 mRNA | CTD | PMID:25825206 | Fbln2 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of FBLN2 mRNA | CTD | PMID:28959563 | Fbln2 | Rat | acrylamide | decreases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of FBLN2 mRNA | CTD | PMID:32763439 | Fbln2 | Rat | aflatoxin B1 | increases methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of FBLN2 gene; Aflatoxin B1 results in increased methylation more ... | CTD | PMID:27153756|PMID:30157460 | Fbln2 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of FBLN2 intron; aflatoxin B2 results in increased methylation more ... | CTD | PMID:30157460 | Fbln2 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of FBLN2 mRNA | CTD | PMID:30951980 | Fbln2 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FBLN2 mRNA | CTD | PMID:16483693 | Fbln2 | Rat | antirheumatic drug | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of FBLN2 mRNA | CTD | PMID:24449571 | Fbln2 | Rat | arsane | affects methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of FBLN2 gene | CTD | PMID:25304211 | Fbln2 | Rat | arsane | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FBLN2 more ... | CTD | PMID:32525701 | Fbln2 | Rat | arsenic atom | affects methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of FBLN2 gene | CTD | PMID:25304211 | Fbln2 | Rat | arsenic atom | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FBLN2 more ... | CTD | PMID:32525701 | Fbln2 | Rat | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of FBLN2 mRNA | CTD | PMID:36841081 | Fbln2 | Rat | Azoxymethane | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN2 more ... | CTD | PMID:29950665 | Fbln2 | Rat | belinostat | decreases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | belinostat results in decreased expression of FBLN2 mRNA | CTD | PMID:27188386 | Fbln2 | Rat | benzo[a]pyrene | affects expression | ISO | Fbln2 (Mus musculus) | 6480464 | Benzo(a)pyrene affects the expression of FBLN2 mRNA | CTD | PMID:22342234 | Fbln2 | Rat | benzo[a]pyrene | affects methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of FBLN2 5' UTR; Benzo(a)pyrene affects the methylation of FBLN2 intron; more ... | CTD | PMID:27901495|PMID:30157460 | Fbln2 | Rat | benzo[a]pyrene | increases methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of FBLN2 3' UTR; Benzo(a)pyrene results in increased methylation of more ... | CTD | PMID:27901495 | Fbln2 | Rat | benzo[a]pyrene | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FBLN2 mRNA | CTD | PMID:15034205 | Fbln2 | Rat | benzo[e]pyrene | increases methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of FBLN2 intron; benzo(e)pyrene results in increased methylation of FBLN2 more ... | CTD | PMID:30157460 | Fbln2 | Rat | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FBLN2 mRNA | CTD | PMID:18164116 | Fbln2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FBLN2 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:34947998 | Fbln2 | Rat | bisphenol A | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of FBLN2 mRNA | CTD | PMID:32156529 | Fbln2 | Rat | bisphenol A | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of FBLN2 protein | CTD | PMID:34186270 | Fbln2 | Rat | bisphenol A | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FBLN2 mRNA | CTD | PMID:27312807|PMID:37105096 | Fbln2 | Rat | bisphenol AF | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of FBLN2 protein | CTD | PMID:34186270 | Fbln2 | Rat | Bisphenol B | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of FBLN2 protein | CTD | PMID:34186270 | Fbln2 | Rat | bisphenol F | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of FBLN2 mRNA | CTD | PMID:30951980 | Fbln2 | Rat | bisphenol F | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of FBLN2 protein | CTD | PMID:34186270 | Fbln2 | Rat | butanal | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of FBLN2 mRNA | CTD | PMID:26079696 | Fbln2 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Fbln2 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of FBLN2 intron | CTD | PMID:28392331 | Fbln2 | Rat | caffeine | increases expression | EXP | | 6480464 | Caffeine results in increased expression of FBLN2 mRNA | CTD | PMID:20864626 | Fbln2 | Rat | cantharidin | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Cantharidin results in decreased expression of FBLN2 mRNA | CTD | PMID:36907384 | Fbln2 | Rat | carbamazepine | affects expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of FBLN2 mRNA | CTD | PMID:25979313 | Fbln2 | Rat | carbon nanotube | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of FBLN2 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 | Fbln2 | Rat | carnosic acid | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | salvin results in decreased expression of FBLN2 protein | CTD | PMID:35926579 | Fbln2 | Rat | chlorpyrifos | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of FBLN2 mRNA | CTD | PMID:32715474 | Fbln2 | Rat | choline | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Fbln2 | Rat | cisplatin | affects expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Cisplatin affects the expression of FBLN2 mRNA | CTD | PMID:23300844 | Fbln2 | Rat | cisplatin | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of more ... | CTD | PMID:23625948 | Fbln2 | Rat | corticosterone | decreases expression | EXP | | 6480464 | Corticosterone results in decreased expression of FBLN2 mRNA | CTD | PMID:15755911 | Fbln2 | Rat | curcumin | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of FBLN2 mRNA] | CTD | PMID:18200517 | Fbln2 | Rat | dextran sulfate | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN2 more ... | CTD | PMID:29950665 | Fbln2 | Rat | diethylstilbestrol | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of FBLN2 mRNA | CTD | PMID:14664709 | Fbln2 | Rat | dioxygen | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of FBLN2 mRNA | CTD | PMID:24205000 | Fbln2 | Rat | dioxygen | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of FBLN2 mRNA | CTD | PMID:26516004 | Fbln2 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of FBLN2 mRNA | CTD | PMID:25152437 | Fbln2 | Rat | dorsomorphin | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Fbln2 | Rat | doxorubicin | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of FBLN2 mRNA | CTD | PMID:30031762 | Fbln2 | Rat | entinostat | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | entinostat results in increased expression of FBLN2 mRNA | CTD | PMID:26272509 | Fbln2 | Rat | entinostat | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Fbln2 | Rat | ethanol | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Ethanol results in increased expression of FBLN2 mRNA | CTD | PMID:30319688 | Fbln2 | Rat | folic acid | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Fbln2 | Rat | folic acid | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of FBLN2 mRNA | CTD | PMID:25629700 | Fbln2 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of FBLN2 mRNA | CTD | PMID:33387578 | Fbln2 | Rat | iron dichloride | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | ferrous chloride results in increased expression of FBLN2 mRNA | CTD | PMID:35984750 | Fbln2 | Rat | isoprenaline | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of FBLN2 mRNA | CTD | PMID:20003209 | Fbln2 | Rat | L-methionine | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Fbln2 | Rat | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of FBLN2 mRNA | CTD | PMID:22641619 | Fbln2 | Rat | lidocaine | increases expression | EXP | | 6480464 | Lidocaine results in increased expression of FBLN2 mRNA | CTD | PMID:35283115 | Fbln2 | Rat | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of FBLN2 mRNA | CTD | PMID:28801915 | Fbln2 | Rat | methapyrilene | increases methylation | ISO | FBLN2 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of FBLN2 intron; Methapyrilene results in increased methylation of FBLN2 more ... | CTD | PMID:30157460 | Fbln2 | Rat | methoxyacetic acid | increases expression | EXP | | 6480464 | methoxyacetic acid results in increased expression of FBLN2 mRNA | CTD | PMID:20864626 | Fbln2 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of FBLN2 gene | CTD | PMID:35440735 | Fbln2 | Rat | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of FBLN2 mRNA | CTD | PMID:20864626 | Fbln2 | Rat | mono(2-ethylhexyl) phthalate | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of FBLN2 mRNA | CTD | PMID:22401849 | Fbln2 | Rat | Monobutylphthalate | increases expression | EXP | | 6480464 | monobutyl phthalate results in increased expression of FBLN2 mRNA | CTD | PMID:20864626 | Fbln2 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FBLN2 mRNA | CTD | PMID:18164116 | Fbln2 | Rat | nickel sulfate | decreases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of FBLN2 mRNA | CTD | PMID:22714537 | Fbln2 | Rat | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of FBLN2 mRNA | CTD | PMID:33484710 | Fbln2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of FBLN2 mRNA | CTD | PMID:33387578 | Fbln2 | Rat | paricalcitol | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased expression of FBLN2 mRNA | CTD | PMID:17715259 | Fbln2 | Rat | pentanal | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | pentanal results in increased expression of FBLN2 mRNA | CTD | PMID:26079696 | Fbln2 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of FBLN2 mRNA | CTD | PMID:37995155 | Fbln2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FBLN2 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Fbln2 | Rat | permethrin | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Permethrin results in increased expression of FBLN2 mRNA | CTD | PMID:37047231 | Fbln2 | Rat | phenylmercury acetate | decreases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of FBLN2 mRNA | CTD | PMID:26272509 | Fbln2 | Rat | phenylmercury acetate | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Fbln2 | Rat | phosphorus atom | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased expression of FBLN2 mRNA | CTD | PMID:17715259 | Fbln2 | Rat | phosphorus(.) | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased expression of FBLN2 mRNA | CTD | PMID:17715259 | Fbln2 | Rat | potassium dichromate | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of FBLN2 mRNA | CTD | PMID:23608068 | Fbln2 | Rat | progesterone | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Progesterone results in increased expression of FBLN2 mRNA | CTD | PMID:17404688 | Fbln2 | Rat | propanal | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of FBLN2 mRNA | CTD | PMID:26079696 | Fbln2 | Rat | quercetin | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of FBLN2 mRNA | CTD | PMID:15309432 | Fbln2 | Rat | resveratrol | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBLN2 mRNA | CTD | PMID:23557933 | Fbln2 | Rat | SB 431542 | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Fbln2 | Rat | silicon dioxide | decreases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of FBLN2 mRNA | CTD | PMID:25895662 | Fbln2 | Rat | sodium arsenate | multiple interactions | ISO | FBLN2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FBLN2 more ... | CTD | PMID:32525701 | Fbln2 | Rat | sodium arsenite | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of FBLN2 mRNA | CTD | PMID:37682722 | Fbln2 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of FBLN2 mRNA | CTD | PMID:19281266 | Fbln2 | Rat | sunitinib | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of FBLN2 mRNA | CTD | PMID:31533062 | Fbln2 | Rat | tamoxifen | affects expression | ISO | Fbln2 (Mus musculus) | 6480464 | Tamoxifen affects the expression of FBLN2 mRNA | CTD | PMID:17555576 | Fbln2 | Rat | tetrachloromethane | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of FBLN2 mRNA | CTD | PMID:17484886 | Fbln2 | Rat | thimerosal | decreases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of FBLN2 mRNA | CTD | PMID:27188386 | Fbln2 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of FBLN2 mRNA | CTD | PMID:23411599|PMID:34492290 | Fbln2 | Rat | titanium dioxide | decreases expression | ISO | Fbln2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of FBLN2 mRNA | CTD | PMID:23557971 | Fbln2 | Rat | titanium dioxide | decreases methylation | ISO | Fbln2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of FBLN2 promoter | CTD | PMID:35295148 | Fbln2 | Rat | titanium dioxide | multiple interactions | ISO | Fbln2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN2 more ... | CTD | PMID:29950665 | Fbln2 | Rat | trichostatin A | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of FBLN2 mRNA | CTD | PMID:24935251 | Fbln2 | Rat | triclosan | decreases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of FBLN2 mRNA | CTD | PMID:30510588 | Fbln2 | Rat | triphenyl phosphate | affects expression | ISO | FBLN2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of FBLN2 mRNA | CTD | PMID:37042841 | Fbln2 | Rat | triptonide | increases expression | ISO | Fbln2 (Mus musculus) | 6480464 | triptonide results in increased expression of FBLN2 mRNA | CTD | PMID:33045310 | Fbln2 | Rat | valproic acid | increases expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of FBLN2 mRNA | CTD | PMID:23179753|PMID:28001369 | Fbln2 | Rat | valproic acid | affects expression | ISO | FBLN2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of FBLN2 mRNA | CTD | PMID:25979313 | Fbln2 | Rat | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of FBLN2 mRNA | CTD | PMID:29427782 | Fbln2 | Rat | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of FBLN2 gene | CTD | PMID:31079544 | |






















